BACKGROUND: Mobility limitations are prevalent, potentially reversible precursors to mobility loss that may go undetected in older adults. This study evaluates standardized administration of an endurance walk test for identifying unrecognized and impending mobility limitation in community elders. METHODS: Men and women (1480 and 1576, respectively) aged 70-79 years with no reported mobility limitation participating in the Health, Aging and Body Composition study were administered the Long Distance Corridor Walk. Walk performance was examined to determine unrecognized mobility deficits at baseline and predict new self-recognition of mobility limitation within 2 years. RESULTS: On testing, 23% and 36% of men and women evidenced mobility deficits defined as a contraindication to exertion, meeting stopping criteria or exceeding 7 minutes to walk 400 m. Unrecognized deficits increased with age and were more prevalent in blacks, smokers, obese individuals, and infrequent walkers. Within 2 years, 21% and 34% of men and women developed newly recognized mobility limitation; those with baseline unrecognized deficits had higher rates, 40% and 54% (p <.001), respectively. For each additional 30 seconds over 5 minutes needed to walk 400 m, likelihood of newly recognized mobility limitation increased by 65% and 37% in men and women independent of age, race, obesity, smoking status, habitual walking, reported walking ease, and usual gait speed. CONCLUSIONS: A sizable proportion of elders who report no walking difficulty have observable deficits in walking performance that precede and predict their recognition of mobility limitation. Endurance walk testing can help identify these deficits and provide the basis for treatment to delay progression of mobility loss.
BACKGROUND: Mobility limitations are prevalent, potentially reversible precursors to mobility loss that may go undetected in older adults. This study evaluates standardized administration of an endurance walk test for identifying unrecognized and impending mobility limitation in community elders. METHODS:Men and women (1480 and 1576, respectively) aged 70-79 years with no reported mobility limitation participating in the Health, Aging and Body Composition study were administered the Long Distance Corridor Walk. Walk performance was examined to determine unrecognized mobility deficits at baseline and predict new self-recognition of mobility limitation within 2 years. RESULTS: On testing, 23% and 36% of men and women evidenced mobility deficits defined as a contraindication to exertion, meeting stopping criteria or exceeding 7 minutes to walk 400 m. Unrecognized deficits increased with age and were more prevalent in blacks, smokers, obese individuals, and infrequent walkers. Within 2 years, 21% and 34% of men and women developed newly recognized mobility limitation; those with baseline unrecognized deficits had higher rates, 40% and 54% (p <.001), respectively. For each additional 30 seconds over 5 minutes needed to walk 400 m, likelihood of newly recognized mobility limitation increased by 65% and 37% in men and women independent of age, race, obesity, smoking status, habitual walking, reported walking ease, and usual gait speed. CONCLUSIONS: A sizable proportion of elders who report no walking difficulty have observable deficits in walking performance that precede and predict their recognition of mobility limitation. Endurance walk testing can help identify these deficits and provide the basis for treatment to delay progression of mobility loss.
Authors: E F Binder; S J Birge; R Spina; A A Ehsani; M Brown; D R Sinacore; W M Kohrt Journal: J Gerontol A Biol Sci Med Sci Date: 1999-07 Impact factor: 6.053
Authors: Ellen F Binder; Kenneth B Schechtman; Ali A Ehsani; Karen Steger-May; Marybeth Brown; David R Sinacore; Kevin E Yarasheski; John O Holloszy Journal: J Am Geriatr Soc Date: 2002-12 Impact factor: 5.562
Authors: E M Simonsick; M E Lafferty; C L Phillips; C F Mendes de Leon; S V Kasl; T E Seeman; G Fillenbaum; P Hebert; J H Lemke Journal: Am J Public Health Date: 1993-10 Impact factor: 9.308
Authors: E M Simonsick; A B Newman; M C Nevitt; S B Kritchevsky; L Ferrucci; J M Guralnik; T Harris Journal: J Gerontol A Biol Sci Med Sci Date: 2001-10 Impact factor: 6.053
Authors: Jennifer S Brach; Eleanor M Simonsick; Stephen Kritchevsky; Kristine Yaffe; Anne B Newman Journal: J Am Geriatr Soc Date: 2004-04 Impact factor: 5.562
Authors: Caroline A Macera; Sandra A Ham; Michelle M Yore; Deborah A Jones; Barbara E Ainsworth; C Dexter Kimsey; Harold W Kohl Journal: Prev Chronic Dis Date: 2005-03-15 Impact factor: 2.830
Authors: Wendy C King; Scott G Engel; Katherine A Elder; William H Chapman; George M Eid; Bruce M Wolfe; Steven H Belle Journal: Surg Obes Relat Dis Date: 2011-07-23 Impact factor: 4.734
Authors: Urho M Kujala; Pekka Hautasaari; Henri Vähä-Ypyä; Katja Waller; Noora Lindgren; Paula Iso-Markku; Kauko Heikkilä; Juha Rinne; Jaakko Kaprio; Harri Sievänen Journal: Ann Med Date: 2019-03-05 Impact factor: 4.709
Authors: Pablo Martinez-Amezcua; Kunihiro Matsushita; Eleanor M Simonsick; Luigi Ferrucci; Jennifer A Schrack Journal: Atherosclerosis Date: 2018-03-22 Impact factor: 5.162
Authors: Jennifer A Schrack; Pei-Lun Kuo; Amal A Wanigatunga; Junrui Di; Eleanor M Simonsick; Adam P Spira; Luigi Ferrucci; Vadim Zipunnikov Journal: J Gerontol A Biol Sci Med Sci Date: 2019-03-14 Impact factor: 6.053
Authors: Sarinnapha Vasunilashorn; Antonia K Coppin; Kushang V Patel; Fulvio Lauretani; Luigi Ferrucci; Stefania Bandinelli; Jack M Guralnik Journal: J Gerontol A Biol Sci Med Sci Date: 2009-01-31 Impact factor: 6.053